Cargando…
Ginsenoside Rh4 Suppresses Metastasis of Gastric Cancer via SIX1-Dependent TGF-β/Smad2/3 Signaling Pathway
Gastric cancer (GC) is the leading causes of cancer-related death worldwide. Surgery remains the cornerstone of gastric cancer treatment, and new strategies with adjuvant chemotherapy are currently gaining more and more acceptance. Ginsenoside Rh4 has excellent antitumor activity. Conversely, the me...
Autores principales: | Jiang, Hongbo, Ma, Pei, Duan, Zhiguang, Liu, Yannan, Shen, Shihong, Mi, Yu, Fan, Daidi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032069/ https://www.ncbi.nlm.nih.gov/pubmed/35458126 http://dx.doi.org/10.3390/nu14081564 |
Ejemplares similares
-
Ginsenoside Rh4 Suppressed Metastasis of Lung Adenocarcinoma via Inhibiting JAK2/STAT3 Signaling
por: Zhang, Yan, et al.
Publicado: (2022) -
Ginsenoside Rh4 Suppresses Metastasis of Esophageal Cancer and Expression of c-Myc via Targeting the Wnt/β-Catenin Signaling Pathway
por: Chen, Jun, et al.
Publicado: (2022) -
Ginsenoside Rh3 Inhibits Lung Cancer Metastasis by Targeting Extracellular Signal-Regulated Kinase: A Network Pharmacology Study
por: Xue, Xiaodan, et al.
Publicado: (2022) -
Study on the hypnotic effect of rare protopanaxadiol-type and protopanaxatriol-type ginsenosides
por: Mou, Ning, et al.
Publicado: (2019) -
Ginsenoside Rh4 Improves Hepatic Lipid Metabolism and Inflammation in a Model of NAFLD by Targeting the Gut Liver Axis and Modulating the FXR Signaling Pathway
por: Yang, Siming, et al.
Publicado: (2023)